Silhouette

Frederick R Blattner

Scarab Genomics, LLC

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Increasing available choices for conjugate vaccine technology by producing carrier proteins in ...
Scarab Genomics, LLC
Principal Investigator
HHS 2 $852K 08/01/17 07/31/18
Characterization of a low mutation rate E. coli in extended fermentation
Scarab Genomics, LLC
Principal Investigator
HHS 2 $864K 06/01/17 05/31/18
Increasing available choices for conjugate vaccine technology by producing carrier proteins in ...
Scarab Genomics, LLC
Principal Investigator
HHS 2 $154K 12/15/16 05/31/17
Characterization of a low mutation rate E. coli in extended fermentation
Scarab Genomics, LLC
Principal Investigator
HHS 2 $1.55MM 06/01/16 05/31/17
Toxoid adjuvant CRM197 production in a stable reduced genome E. coli strain
Scarab Genomics, LLC
Principal Investigator
HHS 2 $729K 05/01/15 04/30/16
A protease-deficient, low mutation rate E. coli for biotherapeutics production
Scarab Genomics, LLC
Principal Investigator
HHS 2 $713K 07/01/14 06/30/15
Toxoid adjuvant CRM197 production in a stable reduced genome E. coli strain
Scarab Genomics, LLC
Principal Investigator
HHS 2 $733K 05/20/14 04/30/15
A protease-deficient, low mutation rate E. coli for biotherapeutics production
Scarab Genomics, LLC
Principal Investigator
HHS 2 $911K 09/01/13 06/30/14
Characterization of a low mutation rate E. coli in extended fermentation
Scarab Genomics, LLC
Principal Investigator
HHS 1 $298K 05/01/13 10/31/13
A protease-deficient, low mutation rate E. coli for biotherapeutics production
Scarab Genomics, LLC
Principal Investigator
HHS 2 $155K 09/27/12 03/26/13
Toxoid adjuvant CRM197 production in a stable reduced genome E. coli strain
Scarab Genomics, LLC
Principal Investigator
HHS 1 $141K 09/05/12 02/28/13
Innate Immune Protection by Clean Genome E. coli
Scarab Genomics, LLC
Principal Investigator
HHS 2 $737K 03/01/12 02/28/13
Innate Immune Protection by Clean Genome E. coli
Scarab Genomics, LLC
Principal Investigator
HHS 2 $996K 03/01/11 02/29/12
Improved bacterial strains for therapeutic DNA and protein production
Scarab Genomics, LLC
Principal Investigator
HHS 2 $837K 09/01/10 02/29/12
Uniform length DNA for paired end nextgen sequencing via in vitro packaging
Scarab Genomics, LLC
Principal Investigator
HHS 1 $127K 06/04/10 11/30/10
Innate Immune Protection by Clean Genome E. coli
Scarab Genomics, LLC
Principal Investigator
HHS 2 $140K 04/01/10 02/28/11
Improved bacterial strains for therapeutic DNA and protein production
Scarab Genomics, LLC
Principal Investigator
HHS 2 $989K 09/10/09 08/31/10
Engineered revision of the E. coli Nissle 1917 Genome
Scarab Genomics, LLC
Principal Investigator
HHS 1 $141K 07/01/08 12/31/09
Clean-Genome vaccines against biodefense agents
Scarab Genomics, LLC
Principal Investigator
HHS 1 $500K 07/01/07 12/30/08
Improved bacterial strains for therapeutic DNA production
Scarab Genomics, LLC
Principal Investigator
HHS 1 $139K 05/01/07 10/31/07
Clean-Genome vaccines against biodefense agents
Scarab Genomics, LLC
Principal Investigator
HHS 1 $500K 07/01/06 06/30/07
Engineered Revision of E. coli for Production of DNA, Proteins and Metabolites
Scarab Genomics, LLC
Principal Investigator
HHS 2 $681K 07/01/06 06/30/07
Engineering E. coli for periplasmic protein production
Scarab Genomics, LLC
Principal Investigator
HHS 2 $312K 09/01/05 02/28/07
Engineered Revision of E. coli for Production of DNA, Proteins and Metabolites
Scarab Genomics, LLC
Principal Investigator
HHS 2 $656K 07/01/05 06/30/06
Engineering E. coli for periplasmic protein production
Scarab Genomics, LLC
Principal Investigator
HHS 2 $729K 09/01/04 08/31/05
Engineered Revision of the E. coli Genome for Production
Scarab Genomics, LLC
Principal Investigator
HHS 1 $100K 07/01/04 12/31/04
Engineering E. coli for periplasmic protein production
Scarab Genomics, LLC
Principal Investigator
HHS 2 $109K 01/16/04 08/31/04